Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06117280 · ClinicalTrials.gov registry record · NA

Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus

A NA study of Energy and Focus, sponsored by Iovate Health Sciences International.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT06117280 is a NA study of Energy and Focus that has completed, run by Iovate Health Sciences International. The registered enrollment target is 45 participants, below the 859-participant average among 7 other Energy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06117280, a NA study of Energy and Focus, has completed, sponsored by Iovate Health Sciences International.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

Research has shown that acute ingestion of Paraxanthine (1,7-dimethylxanthine, PXN) can enhance various markers of focus, including memory, reaction time, and attention in healthy adults. To assess these effects, this placebo-controlled crossover trial will compare the effects of 200 and 300mg of PXN to a placebo control. Participants will abstain from caffeine for 3 days, before taking the first test/placebo product for 3 consecutive days. Participants will complete questionnaires at 30, 60, 90, and 120 minutes after ingestion on Day 1 and Day 3 of ingestion. Participants will have a 3-day washout period before trialing the next test product/placebo.

Interventions

  • OTHER Placebo
  • OTHER Paraxanthine 200 mg
  • OTHER Paraxanthine 300 mg

Study Locations (1)

California

  • Citruslabs - Santa Monica

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2023-07-18
Est. Completion 2023-10-20
Phase NA

What the Registry Record Tells You About NCT06117280

The ClinicalTrials.gov registry entry for NCT06117280 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 859-participant average among 7 other Energy trials with a reported enrollment target (95% lower). The listed sponsor is Iovate Health Sciences International, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Energy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06117280 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06117280 about?

NCT06117280 is a clinical study titled "Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus". Research has shown that acute ingestion of Paraxanthine (1,7-dimethylxanthine, PXN) can enhance various markers of focus, including memory, reaction time, and attention in healthy adults. To assess these effects, this placebo-controlled crossover trial will compare the effects of 200 and 300mg of PX...

What is the current status of trial NCT06117280?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2023-07-18. Estimated completion is 2023-10-20.

What conditions does trial NCT06117280 study?

This clinical trial studies the following conditions: Energy, Focus, Caffeine Withdrawal.

What interventions are being tested in trial NCT06117280?

The interventions under investigation include: Placebo (OTHER), Paraxanthine 200 mg (OTHER), Paraxanthine 300 mg (OTHER).

Who is sponsoring clinical trial NCT06117280?

This trial is sponsored by Iovate Health Sciences International, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06117280 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Energy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.